Internal Medicine, Endocrinology, Diabetes, & Metabolism · Fall River, MA
NPI
1578557807
Since 2005
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
235 Hanover St
Fall River, MA, 02720
Phone (508) 679-7742
Groups this clinician bills Medicare through
Medicare paid, 2024
$300K
12,782 services
Medicare patients, 2024
984
Average age 71
Drug cost, 2024
$6.7M
11,323 prescriptions
Company payments, 2025
$173K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tamer Yacoub was code 99214 (office e&m - established), 1,221 times for 700 patients. In total Tamer Yacoub billed 12,782 services in 69 codes, and Medicare paid $300K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,221 | 700 | $95.23 | $116K |
| 36415 Venipuncture Blood Collection | Office | 1,029 | 629 | $8.64 | $8,892 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 881 | 606 | $12.74 | $11K |
| 84443 Clinical Chemistry | Office | 751 | 498 | $16.46 | $12K |
| 83036 Blood Count | Office | 740 | 447 | $9.49 | $7,026 |
| 80061 Clinical Chemistry | Office | 734 | 459 | $13.09 | $9,610 |
| 82962 Clinical Chemistry | Office | 670 | 410 | $3.21 | $2,147 |
| 84450 Clinical Chemistry | Office | 654 | 415 | $5.07 | $3,314 |
| 84460 Clinical Chemistry | Office | 651 | 412 | $5.18 | $3,370 |
| 82570 Clinical Chemistry | Office | 612 | 393 | $5.06 | $3,099 |
| 82043 Clinical Chemistry | Office | 612 | 393 | $5.63 | $3,448 |
| 84439 Clinical Chemistry | Office | 504 | 381 | $8.84 | $4,455 |
| 82565 Clinical Chemistry | Office | 470 | 281 | $5.00 | $2,351 |
| 84132 Clinical Chemistry | Office | 391 | 219 | $4.64 | $1,814 |
| 95251 Test - Miscellaneous | Office | 390 | 200 | $26.09 | $10K |
By year: 2022 $279K for 9,193 services; 2023 $229K for 9,085 services; 2024 $300K for 12,782 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,029 | 629 | $8.64 | $8,892 |
| 84443 Clinical Chemistry | 751 | 498 | $16.46 | $12K |
| 83036 Blood Count | 740 | 447 | $9.49 | $7,026 |
| 80061 Clinical Chemistry | 734 | 459 | $13.09 | $9,610 |
| 82962 Clinical Chemistry | 670 | 410 | $3.21 | $2,147 |
| 84450 Clinical Chemistry | 654 | 415 | $5.07 | $3,314 |
| 84460 Clinical Chemistry | 651 | 412 | $5.18 | $3,370 |
| 82043 Clinical Chemistry | 612 | 393 | $5.63 | $3,448 |
| 82570 Clinical Chemistry | 612 | 393 | $5.06 | $3,099 |
| 84439 Clinical Chemistry | 504 | 381 | $8.84 | $4,455 |
Medicare prescription drug claims, 2024
In 2024, the drug Tamer Yacoub prescribed most often to Medicare patients was Levothyroxine Sodium, with 796 prescriptions and refills. In total Tamer Yacoub wrote 11,323 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 796 | 2,201 | 223 | $8,626 |
| Jardiance Empagliflozin | 669 | 1,535 | 179 | $868K |
| Atorvastatin Calcium Generic | 640 | 1,743 | 183 | $7,206 |
| Rosuvastatin Calcium Generic | 605 | 1,594 | 176 | $15K |
| Ozempic Semaglutide | 590 | 915 | 115 | $852K |
| Ezetimibe Generic | 438 | 1,195 | 140 | $16K |
| Lisinopril Generic | 372 | 985 | 104 | $2,646 |
| Metformin Hcl Er Metformin Hcl | 341 | 951 | 101 | $3,625 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 315 | 783 | 99 | $56K |
| Trulicity Dulaglutide | 308 | 460 | 85 | $440K |
| Farxiga Dapagliflozin Propanediol | 300 | 578 | 74 | $316K |
| Carvedilol Generic | 223 | 623 | 66 | $2,007 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 216 | 488 | 87 | $27K |
| Mounjaro Tirzepatide | 211 | 275 | 47 | $287K |
| Repaglinide Generic | 207 | 529 | 65 | $8,171 |
Brand drugs: 4,716 claims; generic drugs: 5,890 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tamer Yacoub $173K ($173K in general payments such as food, travel and fees) from 34 companies. The largest payer was Lilly USA, LLC with $48K.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 57 | $48K |
| Ascendis Pharma Endocrinology Inc ASND | 29 | $32K |
| Abbott Laboratories ABT | 65 | $32K |
| Novo Nordisk Inc NVO | 45 | $26K |
| Corcept Therapeutics CORT | 21 | $15K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 23 | $8,450 |
| Xeris Pharmaceuticals, Inc. | 18 | $7,608 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $1,642 |
| Amgen Inc. AMGN | 24 | $777 |
| CeQur Corporation | 1 | $305 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.